Therapeutic Potential of Indian Medicinal Herbs and Current Therapeutic
Approach used to Mitigate the Symptoms of Chronic Fatigue Syndrome:
A Review

Nisha      Singh; Rahul   Kumar   Sharma; Ajay   Singh   Kushwah; Manish      Kumar
Abstract

Chronic fatigue syndrome (CFS) is a complex condition marked by severe exhaustion that lasts at least 6 months. The global prevalence of CFS ranging between 0.4% and 2.5% is growing. Women are affected by CFS more often than men. It is considered a common condition in developed countries. There is no approved treatment for CFS but symptoms can be managed and controlled persistent exhaustion causes significant impairment in daily routine activities. Lowered ATP synthesis, mitochondrial impairment, decreased oxidative phosphorylation, disruption of the hypothalamic–pituitary–adrenal (HPA) axis, and an imbalance of brain neurotransmitters play a major role in the pathophysiology of CFS. The purpose of the present study is to figure out the several plants that are used as a source of medication in chronic fatigue syndrome (CFS) and its current therapeutic approach. The Indian medicinal herbs described in this article are very efficacious in the management of chronic fatigue syndrome symptoms due to the presence of phytochemicals. This review article also covers the current therapeutic approach for chronic fatigue syndrome in a concise form that comprises CBT (Cognitive based therapy), GET (Graded exercise therapy), usage of immunoglobins, psychodynamic counseling, and yoga therapy that includes isometric yoga and yoga nidra are very beneficial in alleviating the symptoms of chronic fatigue syndrome. Antidepressants, immunomodulatory agents, and corticosteroids come under conventional medication for CFS. This article explores different Indian medicinal herbs, their pharmacological properties, and their potential role and current treatments for reducing the severity of symptoms of chronic fatigue syndrom
[1]
Wyller VB. The chronic fatigue syndrome? an update. Acta Neurol Scand  2007; 115(s187): 7-14.
 [http://dx.doi.org/10.1111/j.1600-0404.2007.00840.x] [PMID: 17419822]

[2]
Moss-Morris R, Deary V, Castell B. Chronic fatigue syndrome. Handb Clin Neurol  2013; 110: 303-14.
 [http://dx.doi.org/10.1016/B978-0-444-52901-5.00025-3] [PMID: 23312650]

[3]
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med  1994; 121(12): 953-9.
 [http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009] [PMID: 7978722]

[4]
Jorgensen R. Chronic fatigue: an evolutionary concept analysis. J Adv Nurs  2008; 63(2): 199-207.
 [http://dx.doi.org/10.1111/j.1365-2648.2008.04649.x] [PMID: 18638162]

[5]
Whitehead LC. Quest, chaos and restitution: Living with chronic fatigue syndrome/myalgic encephalomyelitis. Soc Sci Med  2006; 62(9): 2236-45.
 [http://dx.doi.org/10.1016/j.socscimed.2005.09.008] [PMID: 16236413]

[6]
Butler S, Chalder T, Ron M, Wessely S. Cognitive behaviour therapy in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry  1991; 54(2): 153-8.
 [http://dx.doi.org/10.1136/jnnp.54.2.153] [PMID: 2019842]

[7]
Skapinakis P, Lewis G, Mavreas V. Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry  2003; 182(3): 205-9.
 [http://dx.doi.org/10.1192/bjp.182.3.205] [PMID: 12611782]

[8]
Prins JB, Bleijenberg G, van der Meer JWM. Chronic fatigue syndrome – Authors’ reply. Lancet  2006; 367(9522): 1575.
 [http://dx.doi.org/10.1016/S0140-6736(06)68689-3]

[9]
Reyes M, Nisenbaum R, Hoaglin DC, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med  2003; 163(13): 1530-6.
 [http://dx.doi.org/10.1001/archinte.163.13.1530] [PMID: 12860574]

[10]
Kendell P. Chronic fatigue, viruses, and depression. Lancet  1991; 337(8734): 160-2.
 [http://dx.doi.org/10.1016/0140-6736(91)90814-6] [PMID: 1670800]

[11]
Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: Review of history, clinical features, and controversies. Saudi J Med Med Sci  2013; 1(1): 11.
 [http://dx.doi.org/10.4103/1658-631X.112905]

[12]
Chen R, Liang FX, Moriya J, et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res  2008; 36(5): 867-74.
 [http://dx.doi.org/10.1177/147323000803600501] [PMID: 18831878]

[13]
Ferrero K, Silver M, Cocchetto A, Masliah E, Langford D. CNS findings in chronic fatigue syndrome and a neuropathological case report. J Investig Med  2017; 65(6): 974-83.
 [http://dx.doi.org/10.1136/jim-2016-000390] [PMID: 28386034]

[14]
Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann N Y Acad Sci  2006; 1088(1): 230-7.
 [http://dx.doi.org/10.1196/annals.1366.020] [PMID: 17192569]

[15]
Yamamoto S, Ouchi Y, Nakatsuka D, et al. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLoS One  2012; 7(12): e51515.
 [http://dx.doi.org/10.1371/journal.pone.0051515] [PMID: 23240035]

[16]
Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJF. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med  2005; 39(5): 584-9.
 [http://dx.doi.org/10.1016/j.freeradbiomed.2005.04.020] [PMID: 16085177]

[17]
Morris G, Anderson G, Galecki P, Berk M, Maes M. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med  2013; 11(1): 64.
 [http://dx.doi.org/10.1186/1741-7015-11-64]

[18]
Nijs J, Nees A, Paul L, et al. Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review. Exerc Immunol Rev  2014; 20: 94-116.
 [PMID: 24974723]

[19]
Papadopoulos AS, Cleare AJ. Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol  2012; 8(1): 22-32.
 [http://dx.doi.org/10.1038/nrendo.2011.153]

[20]
Tomas C, Newton J. A review of hypothalamic- Pituitary-adrenal axis function in chronic fatigue syndrome. Int Sch Res Notices 2013.

[21]
Chia JKS. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol  2005; 58(11): 1126-32.
 [http://dx.doi.org/10.1136/jcp.2004.020255] [PMID: 16254097]

[22]
Montoya JG, Kogelnik AM, Bhangoo M, et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol  2013; 85(12): 2101-9.
 [http://dx.doi.org/10.1002/jmv.23713] [PMID: 23959519]

[23]
Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern Med Rev  2001; 6(5): 450-9.
 [PMID: 11703165]

[24]
Vecchiet J, Cipollone F, Falasca K, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett  2003; 335(3): 151-4.
 [http://dx.doi.org/10.1016/S0304-3940(02)01058-3] [PMID: 12531455]

[25]
Wirth K, Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Autoimmun Rev  2020; 19(6): 102527.
 [http://dx.doi.org/10.1016/j.autrev.2020.102527] [PMID: 32247028]

[26]
Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev  2000; 5(2): 93-108.
 [PMID: 10767667]

[27]
Rimes KA, Chalder T. Treatments for chronic fatigue syndrome. Occup Med (Lond)  2005; 55(1): 32-9.
 [http://dx.doi.org/10.1093/occmed/kqi015] [PMID: 15699088]

[28]
Castro-Marrero J, Sáez-Francàs N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome. Br J Pharmacol  2017; 174(5): 345-69.
 [http://dx.doi.org/10.1111/bph.13702] [PMID: 28052319]

[29]
Theoharides TC, Asadi S, Weng Z, Zhang B. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol  2011; 31(4): 403-5.
 [http://dx.doi.org/10.1097/JCP.0b013e318225848c] [PMID: 21694612]

[30]
Attree EA, Arroll MA, Dancey CP, Griffith C, Bansal AS. Psychosocial factors involved in memory and cognitive failures in people with myalgic encephalomyelitis/chronic fatigue syndrome. Psychol Res Behav Manag  2014; 7: 67-76.
 [PMID: 24596470]

[31]
Jackson JL, O’Malley PG, Kroenke K. Antidepressants and cognitive-behavioral therapy for symptom syndromes. CNS Spectr  2006; 11(3): 212-22.
 [http://dx.doi.org/10.1017/S1092852900014383] [PMID: 16575378]

[32]
Pae CU, Marks DM, Patkar AA, Masand PS, Luyten P, Serretti A. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother  2009; 10(10): 1561-70.
 [http://dx.doi.org/10.1517/14656560902988510] [PMID: 19514866]

[33]
Sanders P, Korf J. Neuroaetiology of chronic fatigue syndrome: An overview. World J Biol Psychiatry  2008; 9(3): 165-71.
 [http://dx.doi.org/10.1080/15622970701310971] [PMID: 17853290]

[34]
Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev  2005; 15(1): 29-58.
 [http://dx.doi.org/10.1007/s11065-005-3588-2] [PMID: 15929497]

[35]
Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramírez G. Interventions for the treatment and management of chronic fatigue syndrome: A systematic review. JAMA  2001; 286(11): 1360-8.
 [http://dx.doi.org/10.1001/jama.286.11.1360] [PMID: 11560542]

[36]
Alraek T, Lee MS, Choi TY, Cao H, Liu J. Complementary and alternative medicine for patients with chronic fatigue syndrome: A systematic review. BMC Complement Altern Med  2011; 11(1): 87.
 [http://dx.doi.org/10.1186/1472-6882-11-87] [PMID: 21982120]

[37]
Butler A, Chapman J, Forman E, Beck A. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev  2006; 26(1): 17-31.
 [http://dx.doi.org/10.1016/j.cpr.2005.07.003] [PMID: 16199119]

[38]
Nijhof SL, Bleijenberg G, Uiterwaal CSPM, Kimpen JLL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet  2012; 379(9824): 1412-8.
 [http://dx.doi.org/10.1016/S0140-6736(12)60025-7] [PMID: 22385683]

[39]
Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med  2006; 99(10): 506-20.
 [PMID: 17021301]

[40]
Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev  2019; 10(10): CD003200.
 [PMID: 31577366]

[41]
Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol  2005; 10(2): 245-59.
 [http://dx.doi.org/10.1177/1359105305049774] [PMID: 15723894]

[42]
Windgassen S, Goldsmith K, Moss-Morris R, Chalder T. Establishing how psychological therapies work: the importance of mediation analysis. J Ment Health  2016; 25(2): 93-9.
 [http://dx.doi.org/10.3109/09638237.2015.1124400] [PMID: 26732531]

[43]
Ridsdale L, Godfrey E, Chalder T, et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract  2001; 51(462): 19-24.
 [PMID: 11271868]

[44]
Bentler SE, Hartz AJ, Kuhn EM. Prospective observational study of treatments for unexplained chronic fatigue. J Clin Psychiatry  2005; 66(5): 625-32.
 [http://dx.doi.org/10.4088/JCP.v66n0513] [PMID: 15889950]

[45]
Yoshihara K, Hiramoto T, Oka T, Kubo C, Sudo N. Effect of 12 weeks of yoga training on the somatization, psychological symptoms, and stress-related biomarkers of healthy women. Biopsychosoc Med  2014; 8(1): 1-9.
 [http://dx.doi.org/10.1186/1751-0759-8-1] [PMID: 24383884]

[46]
Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K. Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial. Biopsychosoc Med  2014; 8(1): 27.
 [http://dx.doi.org/10.1186/s13030-014-0027-8] [PMID: 25525457]

[47]
Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM  2008; 101(12): 961-5.
 [http://dx.doi.org/10.1093/qjmed/hcn123] [PMID: 18805903]

[48]
Kamei T, Toriumi Y, Kimura H, Kumano H, Ohno S, Kimura K. Decrease in serum cortisol during yoga exercise is correlated with alpha wave activation. Percept Mot Skills  2000; 90(3): 1027-32.
 [http://dx.doi.org/10.2466/pms.2000.90.3.1027] [PMID: 10883793]

[49]
Pullen PR, Nagamia SH, Mehta PK, et al. Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail  2008; 14(5): 407-13.
 [http://dx.doi.org/10.1016/j.cardfail.2007.12.007] [PMID: 18514933]

[50]
Kiecolt-Glaser JK, Christian L, Preston H, et al. Stress, inflammation, and yoga practice. Psychosom Med  2010; 72(2): 113-21.
 [http://dx.doi.org/10.1097/PSY.0b013e3181cb9377] [PMID: 20064902]

[51]
Barrows KA, Jacobs BP. Mind-body medicine: An introduction and review of the literature. Med Clin North Am  2002; 86(1): 11-31.
 [http://dx.doi.org/10.1016/S0025-7125(03)00069-5] [PMID: 11795084]

[52]
Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol  2002; 53(1): 83-107.
 [http://dx.doi.org/10.1146/annurev.psych.53.100901.135217] [PMID: 11752480]

[53]
Yadav R, Mehta M, Mahapatra SC, Magan D, Mehta N. A short-term, comprehensive, yoga-based lifestyle intervention is efficacious in reducing anxiety, improving subjective well-being and personality. Int J Yoga  2012; 5(2): 134-9.
 [http://dx.doi.org/10.4103/0973-6131.98235] [PMID: 22869998]

[54]
Telles S, Gaur V, Balkrishna A. Effect of a yoga practice session and a yoga theory session on state anxiety. Percept Mot Skills  2009; 109(3): 924-30.
 [http://dx.doi.org/10.2466/pms.109.3.924-930] [PMID: 20178291]

[55]
Gupta N, Khera S, Vempati RP, Sharma R, Bijlani RL. Effect of yoga based lifestyle intervention on state and trait anxiety. Indian J Physiol Pharmacol  2006; 50(1): 41-7.
 [PMID: 16850902]

[56]
Stringer EA, Baker KS, Carroll IR, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology. J Transl Med  2013; 11(1): 93.
 [http://dx.doi.org/10.1186/1479-5876-11-93] [PMID: 23570606]

[57]
Sutin AR, Terracciano A, Deiana B, et al. High Neuroticism and low Conscientiousness are associated with interleukin-6. Psychol Med  2010; 40(9): 1485-93.
 [http://dx.doi.org/10.1017/S0033291709992029] [PMID: 19995479]

[58]
Yadav RK, Sarvottam K, Magan D, Yadav R. A two-year follow-up case of chronic fatigue syndrome: substantial improvement in personality following a yoga-based lifestyle intervention. J Altern Complement Med  2015; 21(4): 246-9.
 [http://dx.doi.org/10.1089/acm.2014.0055] [PMID: 25825998]

[59]
Deuskar M.  Stress reduction through yoga Nidra. Proceedings “Yoga – the Light of Microuniverse” of the International Interdisciplinary Scientific Conference “Yoga in Science – Future and Perspectives”. September 23-24; Belgrade, Serbia. 2010; pp. 72-80.

[60]
Paul A, Khan ML, Arunachalam A, Arunachalam K. Biodiversity and conservation of rhododendrons in Arunachal Pradesh in Indo-Burman biodiversity hotspot. Curr Sci  2005; 89: 623-34.

[61]
Saxena M, Saxena J, Neema R, Singh D, Gupta A. Phytochemistry of medicinal plants. J Pharmacogn Phytochem  2013; 6: 168-82.

[62]
Thaipong K, Boonprakob U, Crosby K, Cisneros-Zevallos L, Hawkins Byrne D. Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J Food Compos Anal  2006; 19(6-7): 669-75.
 [http://dx.doi.org/10.1016/j.jfca.2006.01.003]

[63]
Seth SD, Sharma B. Medicinal plants in India. Indian J Med Res  2004; 120(1): 9-11.
 [PMID: 15299226]

[64]
Roy Chengappa KN, Gannon JM, Forrest PE. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. J Ayurveda Integr Med  2014; 5(4): 241-5.
 [http://dx.doi.org/10.4103/0975-9476.146566] [PMID: 25624699]

[65]
Kaur G, Kulkarni SK. S.K. Kulkarni and G. Kaur, Comparative study of Antidepressants and Herbal Psychotropic drugs in a mouse model of chronic fatigue syndrome. J Chronic Fatigue Syndr  2000; 6(2): 23-35.
 [http://dx.doi.org/10.1300/J092v06n02_04]

[66]
Abbas SS, Singh N. Anti-stress Agents (Herbs) of Indian Origin–Herbal Drugs, A Twenty First Century Perspective Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization(DRDO).  Delhi: Government of India 2006; pp. 578-91.

[67]
Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav  2003; 75(3): 547-55.
 [http://dx.doi.org/10.1016/S0091-3057(03)00110-2] [PMID: 12895672]

[68]
Rice-Evans C. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med  1999; 220(4): 262-6.
 [http://dx.doi.org/10.1046/j.1525-1373.1999.d01-45.x] [PMID: 10202400]

[69]
Feng Q, Torii Y, Uchida K, Nakamura Y, Hara Y, Osawa T. Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures. J Agric Food Chem  2002; 50(1): 213-20.
 [http://dx.doi.org/10.1021/jf010875c] [PMID: 11754570]

[70]
Ishikawa T, Suzukawa M, Ito T, et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr  1997; 66(2): 261-6.
 [http://dx.doi.org/10.1093/ajcn/66.2.261] [PMID: 9250103]

[71]
Klaunig JE, Xu Y, Han C, et al. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med  1999; 220(4): 249-54.
 [http://dx.doi.org/10.1046/j.1525-1373.1999.d01-43.x] [PMID: 10202398]

[72]
Pearson DA, Frankel ENR. Aeschbach andJ.B. German, Inhibitionof endothelial cell mediated low-density lipoprotein oxidationby green tea extracts. J Agric Food Chem  1998; 46: 1445-9.
 [http://dx.doi.org/10.1021/jf970889b]

[73]
Y.L.Lin andJ.K. Lin, (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-_B. Mol Pharmacol  1997; 52: 465-72.
 [http://dx.doi.org/10.1124/mol.52.3.465] [PMID: 9281609]

[74]
Sueoka N, Suganuma M, Sueoka E, et al. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci  2001; 928(1): 274-80.
 [http://dx.doi.org/10.1111/j.1749-6632.2001.tb05656.x] [PMID: 11795518]

[75]
Sachdeva AK, Kuhad A. V. Tiwari andK. Chopra, Epigallocatechin gallate ameliorates Chronic fatigue syndrome in mice: Behavioural and biochemical evidence. Behav Brain Res  2009; 205: 414-20.
 [http://dx.doi.org/10.1016/j.bbr.2009.07.020] [PMID: 19643148]

[76]
Goyal RK, Singh J, Lal H. Asparagus racemosus--an update. Indian J Med Sci  2003; 57(9): 408-14.
 [PMID: 14515032]

[77]
Hayes PY, Jahidin AH, Lehman R, Penman KW. Kitching andJ.J. De Voss, Structural revision of shatavarins I and IV, the major components from the roots of A. racemosus. Tetrahedron Lett  2006; 47: 6965-9.
 [http://dx.doi.org/10.1016/j.tetlet.2006.07.121]

[78]
Velavan S, Nagulendran K, Mahesh R, Hazeena Begum V. In vitroantioxidant activity of Asparagus racemosus root. Pharmacogn Mag  2007; 3: 26.

[79]
Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res  1999; 13(4): 275-91.
 [http://dx.doi.org/10.1002/(SICI)1099-1573(199906)13:4<275:AID-PTR510>3.0.CO;2-S] [PMID: 10404532]

[80]
Francis G, Kerem ZHPS. Makkar andK. Becker, The biological action of saponins in animal system: A review. Br J Nutr  2002; 88: 587-605.
 [http://dx.doi.org/10.1079/BJN2002725] [PMID: 12493081]

[81]
Joshi T, Sah SP, Singh A. Antistress activity of ethanolic extract of Asparagus racemosus Willd roots in mice. Indian J Exp Biol  2012; 50(6): 419-24.
 [PMID: 22734253]

[82]
Lestari MLAD, Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol  2014; 39: 113-204.
 [http://dx.doi.org/10.1016/B978-0-12-800173-8.00003-9] [PMID: 24794906]

[83]
Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J  2013; 15(1): 195-218.
 [http://dx.doi.org/10.1208/s12248-012-9432-8] [PMID: 23143785]

[84]
Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol  2009; 41(1): 40-59.
 [http://dx.doi.org/10.1016/j.biocel.2008.06.010] [PMID: 18662800]

[85]
Sahebkar A, Serban MC, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J Funct Foods  2015; 18: 898-909.
 [http://dx.doi.org/10.1016/j.jff.2015.01.005]

[86]
Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K. Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology  2009; 214(1): 33-9.
 [http://dx.doi.org/10.1016/j.imbio.2008.04.003] [PMID: 19159825]

[87]
Lopresti AL, Drummond PD. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. J Affect Disord  2017; 207: 188-96.
 [http://dx.doi.org/10.1016/j.jad.2016.09.047] [PMID: 27723543]

[88]
Stojanović G, Dordevic A, Šmelcerović A. Do other Hypericum species have medical potential as St. John’s wort (Hypericum perforatum)? Curr Med Chem  2013; 20(18): 2273-95.
 [http://dx.doi.org/10.2174/0929867311320180001] [PMID: 23521674]

[89]
Ng QX, Venkatanarayanan N, Ho CYX. Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis. J Affect Disord  2017; 210: 211-21.
 [http://dx.doi.org/10.1016/j.jad.2016.12.048] [PMID: 28064110]

[90]
Russo E, Scicchitano F, Whalley BJ, et al. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res  2014; 28(5): 643-55.
 [http://dx.doi.org/10.1002/ptr.5050] [PMID: 23897801]

[91]
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol  2007; 39(1): 44-84.
 [http://dx.doi.org/10.1016/j.biocel.2006.07.001] [PMID: 16978905]

[92]
Singh A, Naidu PS, Gupta S, Kulkarni SK. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food  2002; 5(4): 211-20.
 [http://dx.doi.org/10.1089/109662002763003366] [PMID: 12639396]

[93]
Zhang R, Ji Y, Zhang X, Kennelly EJ, Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol  2020; 254: 112686.
 [http://dx.doi.org/10.1016/j.jep.2020.112686] [PMID: 32101776]

[94]
Garachh D, Patel A, Chakraborty M, Kamath JV. Phytochemical and pharmacological profile of Punica granatum: an overview. Int Res J Pharm  2012; 3: 65-8.

[95]
T. Devi andS. Das, Evaluation of protective effect of ethanolic extract of leaves of Punica granatum Linn. on forced swimming induced Chronic fatigue syndrome in mice. Int J Pharm Pharm Sci  2017; 9: 207-12.

[96]
Kaur S, Sharma N, Nehru B. Anti-inflammatory effects of Ginkgo biloba extract against trimethyltin-induced hippocampal neuronal injury. Inflammopharmacology  2018; 26(1): 87-104.
 [http://dx.doi.org/10.1007/s10787-017-0396-2] [PMID: 28918573]

[97]
Hu H, Li Y, Xin Z, Zhang X. Ginkgolide B exerts anti-inflammatory and chondroprotective activity in LPS-induced chondrocytes. Adv Clin Exp Med  2018; 27(7): 913-20.
 [http://dx.doi.org/10.17219/acem/70414] [PMID: 29905408]

[98]
Kan J, Chen L, Yeh A, Liu B, et al. A botanical product containing cistanche and Ginko extracts improve chronic fatigue syndrome: A randomized, double- blind, placebo controlled study.  Res. Sq 2020; pp. 1-18.

[99]
Sharma PV. Darvyaguna Vijnan.  (4th ed.). Varanasi: Chaukkhamba Sanskrit Sansthan 1978; pp. 763-76.

[100]
Srivastava RS. its Source and Active Principles. Proc  1998; 524.

[101]
Ghosal S. Chemistry of shilajit, an immunomodulatory Ayurvedic rasayan. Pure Appl Chem  1990; 62(7): 1285-8.
 [http://dx.doi.org/10.1351/pac199062071285]

[102]
Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res  2007; 21(5): 401-5.
 [http://dx.doi.org/10.1002/ptr.2100] [PMID: 17295385]

[103]
A.K. Jaiswal andS.K. Bhattacharya, Effects of shilajit on memory, anxiety and brain monoamines in rats. Indian J Pharmacol  1992; 24: 12-7.

[104]
Surapaneni DK, Adapa SRSS, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats. J Ethnopharmacol  2012; 143(1): 91-9.
 [http://dx.doi.org/10.1016/j.jep.2012.06.002] [PMID: 22771318]

[105]
Moon K, Khadabadi SS, Deokate UA, Deore SL. Caesalpinia bonducella Overview. Rep Opinion  2010; 2: 83-90.

[106]
Shukla S, Mehta A, John J, Singh SP. Mehta andS.P. Vyas, Antioxidant activityand total phenolic content of ethanolic extract of Caesalpinia bonducella seeds. Food Chem Toxicol  2009; 47: 1848-51.
 [http://dx.doi.org/10.1016/j.fct.2009.04.040] [PMID: 19422871]

[107]
Sachan NK, Verma S, Sachan AK, Hussain A. An investigation to antioxidant activity of Caesalpinia bonducella seeds. Ann Pharm Pharm Sci  2010; 1: 88-91.

[108]
Sarma P, Borah M, Das S. Evaluation of the protective effect of ethanolic extract of seed kernel of Caesalpinia bonducella Flem (EECB) on forced swimming-induced chronic fatigue syndrome in mice. Pharmacognosy Res  2019; 11(3): 254-9.
 [http://dx.doi.org/10.4103/pr.pr_172_18]

[109]
Sathyapalan T, Beckett S, Rigby AS, Mellor DD, Atkin SL. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J  2010; 9(1): 55.
 [http://dx.doi.org/10.1186/1475-2891-9-55] [PMID: 21092175]

[110]
Peters JC. Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol  1991; 294: 345-58.
 [http://dx.doi.org/10.1007/978-1-4684-5952-4_32] [PMID: 1772073]

[111]
Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am J Clin Nutr  2012; 95(3): 740-51.
 [http://dx.doi.org/10.3945/ajcn.111.023457] [PMID: 22301923]

[112]
Coe S, Axelsson E, Murphy V, et al. Flavonoid rich dark cocoa may improve fatigue in people with multiple sclerosis, yet has no effect on glycaemic response: An exploratory trial. Clin Nutr ESPEN  2017; 21: 20-5.
 [http://dx.doi.org/10.1016/j.clnesp.2017.07.002] [PMID: 30014865]

[113]
Joshi GC, Tewari LM, Lohani N, Upreti K, Jalal JS, Tewari G. Diversity of orchids in Uttarakhand and their conservation strategy with special reference to their medicinal importance. Rep Opinion  2009; 1: 47-52.

[114]
Gutierrez RMP. Orchids: a review of uses in traditional medicine, its phytochemistry and pharmacology. J Med Plants Res  2010; 4: 592-638.

[115]
Majumder PL, Banerjee S, Maiti DC, Sen S. Stilbenoids from the orchids Agrostophyllum callosum and Coelogyne flaccida. Phytochemistry  1995; 39(3): 649-53.
 [http://dx.doi.org/10.1016/0031-9422(95)00942-Z]

[116]
Majumder PL, Sen S, Majumder S. Phenanthrene derivatives from the orchid Coelogyne cristata. Phytochemistry  2001; 58(4): 581-6.
 [http://dx.doi.org/10.1016/S0031-9422(01)00287-4] [PMID: 11576602]

[117]
Chakrabarty M, Datta GK, Ghosh S, Debnath PK. Induction of antioxidative enzyme by the ayurvedic herb Desmotrichum fimbriatum Bl. in mice. Indian J Exp Biol  2001; 39(5): 485-6.
 [PMID: 11510136]

[118]
Kovács A, Vasas A, Hohmann J. Natural phenanthrenes and their biological activity. Phytochemistry  2008; 69(5): 1084-110.
 [http://dx.doi.org/10.1016/j.phytochem.2007.12.005] [PMID: 18243254]

[119]
Mitra A, Kumar ST, Sachhidananda U, Dipankar B, Jayram H. Effect of Swarna jibanti (Coelogyne cristata) in alleviation of Chronic fatigue syndrome in aged wistar rats. J Ayurveda Integr Med  2017; 30: 1-6.

[120]
Fleming T. PDR for Herbal Medicines. Montvale, New Jersey: Medical Economics Company 2000.

[121]
Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food  2006; 9(1): 113-8.
 [http://dx.doi.org/10.1089/jmf.2006.9.113] [PMID: 16579738]

[122]
Sahu R, Dhongade HJ, Pandey A, et al. Medicinal properties of Nardostachys jatamansi: A review. Orient J Chem  2016; 32(2): 859-66.
 [http://dx.doi.org/10.13005/ojc/320211]

[123]
Lyle N, Gomes A, Sur T, et al. The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behav Brain Res  2009; 202(2): 285-90.
 [http://dx.doi.org/10.1016/j.bbr.2009.04.005] [PMID: 19375459]

[124]
Pushpangadan P, Rajasekharan S, Ratheshkumar PK, et al. ‘Arogyappacha’ (Trichopus zeylanicus gaerin), the ‘ginseng’ of kani tribes of agashyar hills (kerala) for ever green healh and vitality. Anc Sci Life  1988; 8(1): 13-6.
 [PMID: 22557622]

[125]
Singh B, Gupta DK, Chandan BK. Adaptogenic activity of a glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaertn. Phytomedicine  2001; 8(4): 283-91.
 [http://dx.doi.org/10.1078/0944-7113-00038] [PMID: 11515718]

[126]
Biju VC. Therapeutic properties of Trichopus zeylanicus subsp. travancoricus, a rare Endangered Medicinal plant in South India: A review. iMedPub  2019; 5: 2.

[127]
Singh AE. Saxena andK.K. Bhutani, Adrenocorticosterone alteration in male, Albino mice treated with Trichopus zeylanicus, Withania Somnifera and Panax ginseng preprations. Phytother Res  2000; 14: 122-5.
 [http://dx.doi.org/10.1002/(SICI)1099-1573(200003)14:2<122:AID-PTR529>3.0.CO;2-S] [PMID: 10685111]

[128]
Rishikesh BRS. Kumar andP. Perumal, Anxiolytic activity and antidepressant activity of saponin fraction of Trichopus zeylanicus gaertn, in mice. Int J Phytopharm  2012; 3: 1-6.

[129]
Singh B, Chandan BK, Sharma N, Singh S, Khajuria A, Gupta DK. Adaptogenic activity of glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaerten (part II). Phytomedicine  2005; 12(6-7): 468-81.
 [http://dx.doi.org/10.1016/j.phymed.2005.01.009] [PMID: 16008124]

[130]
Evans DA, Subramoniam AS. Rajasekharan andP. Pushpangadan, Effect of Trichopus zeylanicus leaf extract on energy metabolism in mice during exercise and at rest. Indian J Pharmacol  2002; 34: 32-7.

[131]
Tharakan BM. Dhanasekaran andB.V. Manyam, Antioxidant and DNA protecting properties of anti-fatigue herb Trichopus zeylanicus. Phytother Res  2005; 8: 19669-73.

[132]
Dorman HJD, Bachmayer O, Kosar M, Hiltunen R. Antioxidant properties of aqueous extracts from selected lamiaceae species grown in Turkey. J Agric Food Chem  2004; 52(4): 762-70.
 [http://dx.doi.org/10.1021/jf034908v] [PMID: 14969528]

[133]
Q. Nizami andM.A. Jafri, Unani drug, Jadwar (Delphinium denudatum Wall.)—a review. Indian J Tradit Knowl  2006; 5: 463-7.

[134]
S. Mohanapriya andG. Vijaiyansiva, Bioactive constituent of Delphinium denudatum Wall. and their antioxidant efficacy. J Acad Ind Res  2013; 2: 138-41.

[135]
Abid M, Gosh AK, Ali Khan N. In vivo Psychopharmacological Investigation of Delphinium Denudatum and Amaranthus Spinosus Extracts on Wistar Rats. Basic Clin Neurosci  2017; 8(6): 503-12.
 [http://dx.doi.org/10.29252/nirp.bcn.8.6.503] [PMID: 29942433]

[136]
Zaheer I, Rahman SZ, Khan RA, Parveen M, Ahmad M. Evaluation of Analgesic Activity of Extracts of Delphinium denudatum in Animal Models: A Dose-dependent Pre-clinical Trial. J Clin Diagn Res  2018; 12: 12.
 [http://dx.doi.org/10.7860/JCDR/2018/37415.12322]

[137]
Hu QL, Zhang LJ, Li YNYJ. Ding andF.L. Li. Purification and anti-fatigue activity of flavonoids from corn silk. Int J Phys Sci  2010; 5: 321-6.

[138]
Su KY, Yu CY, Chen YW, et al. Rutin, a flavonoid and principal component of saussurea involucrata, attenuates physical fatigue in a forced swimming mouse model. Int J Med Sci  2014; 11(5): 528-37.
 [http://dx.doi.org/10.7150/ijms.8220] [PMID: 24693223]

[139]
Puri BK. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol  2006; 60(2): 122-4.
 [http://dx.doi.org/10.1136/jcp.2006.042424] [PMID: 16935966]

[140]
Ruxton CHS, Reed SC, Simpson MJA, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence. J Hum Nutr Diet  2004; 17(5): 449-59.
 [http://dx.doi.org/10.1111/j.1365-277X.2004.00552.x] [PMID: 15357699]

[141]
Daneshfard B, Yekta NH, Khoshdel A, Heiran A, Cheraghi R, Yarmohammadi H. The effect of Delphinium denudatum (Jadwar) on fatigue: A randomized double blind placebo-controlled clinical trial. Complement Ther Med  2019; 46: 29-35.
 [http://dx.doi.org/10.1016/j.ctim.2019.05.027] [PMID: 31519284]

[142]
Gupta RK. Medicinal and aromatic plants.  1st edition. CBS publishers & distributors 2010; p. 116-7.

[143]
Gupta AKN, Tondonand M. Sharma, Quality Standards of Indian Medicinal Plants, medicinal plants unit. Published by Indian Council of Medical Research  2008; 2: 47-53.

[144]
Kirtikar KR, Basu BD. Indian Medicinal Plants. International book distributors  2006; 2: 856-60.

[145]
Nadkarni KM. Indian Materia Medica. Popular Prakashan, Bombay  2009; 1: 285-6.

[146]
Nyeem MA, Haque MS, Hoque MA. M.M. Islam andS. Islam, Cassia fistula Linn: phytochemical and pharmacological studies: A review. Int J Adv Sci Res  2017; 2: 25-30.

[147]
Khare CP. Indian medicinal plants.  Springer 2007; p. 128.
 [http://dx.doi.org/10.1007/978-0-387-70638-2]

[148]
Agarwal SS, Paridhavi M. Clinically useful herbal drugs.  Ahuja publishing house 2005; pp. 281-2.

[149]
Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal plants. Central Drug ResearchInstitute. Lucknow and National Institute of Science Communication and Information Resources, New Delhi  2004; 3: 140.

[150]
Siddhuraju P, Mohan PS, Becker K. Studies on the antioxidant activity of Indian Laburnum (Cassia fistula L.): a preliminary assessment of crude extracts from stem bark, leaves, flowers and fruit pulp. Food Chem  2002; 79(1): 61-7.
 [http://dx.doi.org/10.1016/S0308-8146(02)00179-6]

[151]
Mazumder UK, Gupta M, Rath N. CNS activities of Cassia fistula in mice. Phytother Res  1998; 12(7): 520-2.
 [http://dx.doi.org/10.1002/(SICI)1099-1573(199811)12:7<520:AID-PTR345>3.0.CO;2-O]

[152]
Sarma P, Borah M, Das S. Evaluation of the effect of ethanolic extract of fruit pulp of Cassia fistula Linn. on forced swimming induced chronic fatigue syndrome in mice. Res Pharm Sci  2015; 10(3): 206-13.
 [PMID: 26600847]

[153]
Singh V, Amdekar S, Verma O. Ocimum sanctum (tulsi): Biopharmacological activities. WebmedCentral Pharmacol  2010; 1(10): WMC001046.

[154]
Warrier PK, Nambiar VPK, Ramankutty C. A compendium of 500 species. Indian medicinal plants Orient longman publisher 1995.

[155]
Satyavati GV, Gupta AK, Tandon N. Ocimum sanctum linn. Medicinal plants of India. ICMR, India  1987; 2: 355-71.

[156]
Mediratta PK, Sharma KK, Singh S. Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action. J Ethnopharmacol  2002; 80(1): 15-20.
 [http://dx.doi.org/10.1016/S0378-8741(01)00373-7] [PMID: 11891082]

[157]
Anbarasu K, Vijayalakshmi G. Improved shelf life of protein-rich tofu using Ocimum sanctum (tulsi) extracts to benefit Indian rural population. J Food Sci  2007; 72(8): M300-5.
 [http://dx.doi.org/10.1111/j.1750-3841.2007.00487.x] [PMID: 17995609]

[158]
Gupta P, Yadav DK, Siripurapu KB, Palit G, Maurya R. Constituents of Ocimum sanctum with antistress activity. J Nat Prod  2007; 70(9): 1410-6.
 [http://dx.doi.org/10.1021/np0700164] [PMID: 17850106]

[159]
Joshi H, Parle M. Evaluation of nootropic potential of Ocimum sanctum Linn. in mice. Indian J Exp Biol  2006; 44(2): 133-6.
 [PMID: 16480180]

[160]
Mishra P, Mishra S. Study of antibacterial activity of Ocimum sanctum extract against gram positive and gramnegative bacteria. Am J Food Technol  2011; 6: 336-41.
 [http://dx.doi.org/10.3923/ajft.2011.336.341]

[161]
Hemalatha R, Babu KN, Karthik M, Ramesh R, Kumar BD, Kumar PU. Immunomodulatory activity and Th1/Th2 cytokine response of Ocimum sanctum in myelosuppressed swiss albino mice. Trends in Medical Research  2011; 6(1): 23-31.
 [http://dx.doi.org/10.3923/tmr.2011.23.31]

[162]
Biswas NP, Biswas AK. Evaluation of some leaf dusts as grain protectant against rice weevil Sitophilus oryzae (Linn.). Environ Ecol  2005; 23: 485-8.

[163]
Pandey G, Madhuri S. Pharmacological activities of Ocimum sanctum (tulsi): a review. Int J Pharm Sci Rev Res  2010; 5: 61-6.

[164]
Gupta SK, Prakash J, Srivastava S. Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant. Indian J Exp Biol  2002; 40(7): 765-73.
 [PMID: 12597545]

[165]
Singh N, Verma P, Mishra N, Nath R. A comparative evaluation of some anti-stress agents of plant origin. Indian J Pharmacol  1991; 23: 99-103.

[166]
Kelm MA, Nair MG, Strasburg GM, DeWitt DL. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine  2000; 7(1): 7-13.
 [http://dx.doi.org/10.1016/S0944-7113(00)80015-X] [PMID: 10782484]

[167]
Venu Prasa MP, Khanum F. Antifatigue activity of ethanolic extract of Ocimum sanctum in rats. Res J Med Plant  2012; 6(1): 37-46.
 [http://dx.doi.org/10.3923/rjmp.2012.37.46]
Cite As
Current Traditional Medicine

Therapeutic Potential of Indian Medicinal Herbs and Current Therapeutic Approach used to Mitigate the Symptoms of Chronic Fatigue Syndrome: A Review

Abstract
